001060.KS
JW Pharmaceutical Corporation
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 27,150.00
−2.16%Margins
Gross margin
47.3%
EBITDA margin
15.3%
EBIT margin
13.9%
Net margin
12.3%
FCF margin
13.9%
24.7%
Return on equity
15.3%
Return on assets
23.8%
Return on invested capital
1.28x
Asset turnover
KRW 134.5B
Cash from operations
KRW 2.5K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026